NCT04227535View on ClinicalTrials.gov

Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2

Active, not recruitingOBSERVATIONAL

Enrollment

509

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions

Rheumatoid ArthritisInterstitial Lung Disease

Trial Locations (1)

75018

Bichat Hospital, Paris

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER